Otros idiomas Zenith Capital Corp.

Acciones

ZHCLF

CA98935N1033

Mercado cerrado - OTC Markets Otros sitios de cotización 19:10:50 01/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,1 ^USD	-60,00 %		-50,00 %	-16,67 %

05/04	Zenith Capital Corp. informa de los resultados del tercer trimestre y de los nueve meses finalizados el 31 de enero de 2024	CI
2023	Zenith Capital Corp. informa de los resultados del segundo trimestre y de los seis meses finalizados el 31 de octubre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Zenith Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	05/04
Zenith Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	23/12
Zenith Capital Corp. Reports Earnings Results for the First Quarter Ended July 31, 2023	28/09/23
Zenith Capital Corp. Reports Earnings Results for the Full Year Ended April 30, 2023	29/08/23
Zenith's Bet Inhibitor ZEN-3694 Providing Significant Clinical Benefit in Patients with Aggressive Cancer Type	01/06/23
Zenith Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023	06/04/23
Zenith Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	24/12/22
Zenith Capital Corp. Reports Earnings Results for the First Quarter Ended July 31, 2022	30/09/22
Zenith Capital Corp. Auditor Raises 'Going Concern' Doubt	15/09/22
Zenith Capital Corp. Reports Earnings Results for the Full Year Ended April 30, 2022	15/09/22
Zenith Epigenetics Announces Initiation of Phase 2b Triple Negative Breast Cancer Clinical Trial	10/05/22
Zenith Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2022	01/04/22
Zenith Epigenetics Provides Clinical Update	31/01/22
Zenith Epigenetics Announces Changes to Board of Directors	31/01/22
Zenith Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2021	20/12/21
Newsoara BioPharma Co., Ltd. announced that it expects to receive $1.5 million in funding from Zenith Capital Corp.	15/11/21
Zenith Capital Corp. Reports Earnings Results for the Full Year Ended April 30, 2021	31/08/21
Zenith Capital Corp. Auditor Raises 'Going Concern' Doubt	30/08/21
Zenith Epigenetics Announces a Publication Highlighting the Role of ZEN-3694 in Overcoming Resistance to Therapies in Metastatic Castration-Resistant Prostate Cancer	24/06/21
Zenith Epigenetics Announces Clinical Collaboration with Astellas	22/04/21

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Zenith Capital Corp.

Acciones

ZHCLF

CA98935N1033

Otros idiomas

Filtros